Antibiotics at the crossroads

Nature

Volumn 431, Issue 7011, 2004, Pages 899-902

  Nathan, Carl ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; NEW DRUG; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; BIOTECHNOLOGY; COMBINATORIAL CHEMISTRY; DRUG DESIGN; DRUG INDUSTRY; DRUG MARKETING; DRUG RESEARCH; DRUG USE; GOVERNMENT; HEALTH CARE NEED; HEALTH CARE PLANNING; HIGH RISK POPULATION; HUMAN; INFECTION RISK; INVESTMENT; LIVESTOCK; NOTE; PATENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROFIT; STANDARD; TUBERCULOSIS;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTITUBERCULAR AGENTS; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; DRUG INDUSTRY; DRUG RESISTANCE, BACTERIAL; FOOD INDUSTRY; HUMANS; ORGANIZATIONS, NONPROFIT; PATENTS;

BACTERIA (MICROORGANISMS);

EID: 7244245763     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/431899a     Document Type: Note

References (23)

1. Projan, S. J. Curr. Opin. Microbiol. 6, 427-430 (2003).
2. Wenzel, R. P. N. Engl. J. Med. 351, 523-526 (2004).
3. Infectious Diseases Society of America. Bad Bugs, No Drugs; www.idsociety.org/Template.cfm?Section=Home&CONTENTID=7455&TEMPLATE=/ ContentManagement/ContentDisplay.cfm (2004).
4. Centers for Disease Control and Prevention. A Public Health Action Plan to Combat Antimicrobial Resistance; www.cdc.gov/drugresistance/actionplan/html/ index.htm (2000).
5. Coates, A., Hu, Y., Bax, R. & Page, C. Nature Rev. Drug Discov. 1, 895-910 (2002).
6. World Health Organization Draft Global Strategy for the Containment of Antimicrobial Resistance; www.who.int/emc/amr.html (2001).
7. Service, R. F. Science 303, 1796-1799 (2004).
8. Walsh, C. Nature Rev. Microbiol. 1, 65-70 (2003).
9. Miesel, L., Greene, J. & Black, T. A. Nature Rev. Genet. 4, 442-456 (2003).
10. Global Alliance for Tuberculosis Drug Development. The Economics of TB Drug Development; www.tballiance.org/7_6D_Publications.asp (2001).
11. Chopra, I., Hodgson, J., Metcalf, B. & Poste, G. J. Am. Med. Assoc. 275, 401-403 (1996).
12. Darwin, K. H., Ehrt, S., Gutierrez-Ramos, I. C., Weich, N. & Nathan, C. F. Science 302, 1963-1966 (2003).
13. Bryk, R., Lima, C. D., Erdjument-Bromage, H., Tempst, P. & Nathan, C. Science 295, 1073-1077 (2002).
14. Schnappinger, D. et al. J. Exp. Med. 198, 693-704 (2003).
15. Sassetti, C. M., Boyd, D. H. & Rubin, E. J. Mol. Microbiol. 48, 77-84 (2003).
16. Tong, A. H. et al. Science 303, 808-813 (2004).
17. Fidock, D. A., Rosenthal, P. J., Croft, S. L., Brun, R. & Nwaka, S. Nature Rev. Drug Discov. 3, 509-520 (2004).
18. Manetsch, R. et al. J. Amer. Chem. Soc. 126, 12809-12819 (2004).
19. Keller, M. & Zengler, K. Nature Rev. Microbiol. 2, 141-150 (2004).
20. Liu, J. et al. Nature Biotechnol. 22, 185-191 (2004).
21. Nwaka, S. & Ridley, R. G. Nature Rev. Drug Discov. 2, 919-928 (2003).
22. Vennerstrom, J. L. et al. Nature 430, 900-904 (2004).
23. World Health Organization, Commisssion on Macroeconomics and Health Macroeconomics and Health: Investing in Health for Economic Development; www.cmhealth.org (2001).